Insider trading

Period: 12 months Stock: PHVS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
23 Sep 2026
Monges Viviane Director
Sold at will
$395.52K 11,969 at 33.05
68.5%
Sold half or more
22 Sep 2026
Sold at will
$28.95K 800 at 36.19
0.7%
Not planned
21 Sep 2026
Nassif David W. CFO / CLO
Sold at will
$218.80K 6,000 at 36.47
5.0%
Not planned
17 Sep 2026
Sold at will
$7.00M 200,000 at 35.00
63.5%
Sold half or more
17 Sep 2026
Lu Peng President
Sold at will
$3.50M 100,000 at 35.00
60.6%
Sold half or more
17 Sep 2026
Bjork Elisabeth Director
Sold at will
$1.99M 52,500 at 37.89
77.6%
Sold half or more
17 Sep 2026
Lesage Anne Chief Early Development · indirect
Sold at will
$765.47K 20,000 at 38.27
21.3%
Not planned
17 Sep 2026
Glassman Robert Director
Sold at will
$558.81K 14,493 at 38.56
58.0%
Sold half or more
15 Sep 2026
Abele Stefan Andreas Chief Technical Ops Officer
Sold at will 2×
$1.77M 46,400 at 38.17
54.3%
Sold half or more
15 Sep 2026
Glassman Robert Director
Sold on a plan
$331.72K 8,667 at 38.27
45.2%
Planned (10b5-1)
15 Sep 2026
Souverijns Wim Chief Commercial Officer
Sold on a plan
$237.45K 6,090 at 38.99
13.5%
Planned (10b5-1)
14 Sep 2026
Souverijns Wim Chief Commercial Officer
Sold on a plan
$786.13K 20,000 at 39.31
30.7%
Planned (10b5-1)
14 Sep 2026
Modig Berndt Chief Executive Officer
Sold on a plan
$90.28K 2,291 at 39.40
1.8%
Planned (10b5-1)
11 Sep 2026
Lu Peng President
Sold on a plan
$601.95K 15,000 at 40.13
18.7%
Planned (10b5-1)
10 Sep 2026
Lesage Anne Chief Early Development
Sold on a plan
$1.15M 30,000 at 38.30
34.7%
Planned (10b5-1)
9 Sep 2026
Glassman Robert Director
Sold on a plan
$300.40K 8,000 at 37.55
43.2%
Planned (10b5-1)
8 Sep 2026
Lu Peng President
Sold on a plan
$610.13K 15,000 at 40.68
18.7%
Planned (10b5-1)
14 Aug 2026
Modig Berndt Chief Executive Officer
Sold on a plan
$79.69K 2,292 at 34.77
1.7%
Planned (10b5-1)
13 Jul 2026
Modig Berndt Chief Executive Officer
Sold on a plan
$80.15K 2,292 at 34.97
1.7%
Planned (10b5-1)
30 Jun 2026
Sold on a plan
$1.09M 30,712 at 35.49
8.9%
Planned (10b5-1)
30 Jun 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$1.09M 30,703 at 35.49
24.6%
Planned (10b5-1)
30 Jun 2026
Lesage Anne Chief Early Development
Sold on a plan
$988.89K 27,872 at 35.48
32.2%
Planned (10b5-1)
29 Jun 2026
Lesage Anne Chief Early Development
Sold on a plan 2×
$371.69K 10,600 at 35.07
15.8%
Planned (10b5-1)
29 Jun 2026
Sold on a plan 2×
$325.70K 9,288 at 35.07
2.6%
Planned (10b5-1)
29 Jun 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$245.23K 6,997 at 35.05
5.3%
Planned (10b5-1)
26 Jun 2026
Lu Peng Chief Medical Officer
Sold on a plan
$499.85K 14,700 at 34.00
18.3%
Planned (10b5-1)
25 Jun 2026
Lu Peng Chief Medical Officer
Sold on a plan 2×
$518.98K 15,000 at 34.60
18.6%
Planned (10b5-1)
25 Jun 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$80.79K 2,300 at 35.12
1.7%
Planned (10b5-1)
25 Jun 2026
Lesage Anne Chief Early Development
Sold on a plan
$80.77K 2,300 at 35.12
3.9%
Planned (10b5-1)
18 Jun 2026
Lu Peng Chief Medical Officer
Sold on a plan
$10.20K 300 at 34.00
0.5%
Planned (10b5-1)
15 Jun 2026
Modig Berndt Chief Executive Officer
Sold on a plan 2×
$71.17K 2,291 at 31.07
1.7%
Planned (10b5-1)
4 Jun 2026
Nijdam Anna Principal Accounting Officer
Sold at will
$82.43K 2,670 at 30.87
5.5%
Not planned
22 May 2026
Nijdam Anna Principal Accounting Officer
Sold at will
$169.08K 5,501 at 30.74
10.1%
Not planned
21 May 2026
Nassif David W. CFO / CLO
Sold at will
$303.08K 10,000 at 30.31
7.7%
Not planned
21 May 2026
Monges Viviane Director
Sold at will
$292.85K 9,667 at 30.29
63.7%
Sold half or more
21 May 2026
Nijdam Anna Principal Accounting Officer
Sold at will
$55.97K 1,829 at 30.60
3.6%
Not planned
20 May 2026
Bjork Elisabeth Director
Sold on a plan
$293.17K 10,000 at 29.32
39.7%
Planned (10b5-1)
18 May 2026
Modig Berndt Chief Executive Officer
Sold on a plan
$66.98K 2,292 at 29.22
1.6%
Planned (10b5-1)
15 May 2026
Souverijns Wim Chief Commercial Officer
Sold on a plan
$299.16K 10,000 at 29.92
18.1%
Planned (10b5-1)
15 May 2026
Glassman Robert Director
Sold at will 2×
$298.25K 10,000 at 29.82
48.8%
Not planned
15 May 2026
Abele Stefan Andreas Chief Technical Ops Officer
Sold at will
$260.86K 8,748 at 29.82
19.9%
Not planned
1 May 2026
Lu Peng Chief Medical Officer
Sold on a plan 2×
$427.42K 14,166 at 30.17
17.7%
Planned (10b5-1)
30 Apr 2026
Sold on a plan 2×
$881.38K 29,070 at 30.32
7.6%
Planned (10b5-1)
30 Apr 2026
Lesage Anne Chief Early Development
Sold on a plan 2×
$656.55K 21,700 at 30.26
27.8%
Planned (10b5-1)
30 Apr 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$580.91K 19,200 at 30.26
12.5%
Planned (10b5-1)
30 Apr 2026
Lu Peng Chief Medical Officer
Sold on a plan
$453.63K 15,000 at 30.24
18.5%
Planned (10b5-1)
29 Apr 2026
Sold on a plan
$115.17K 3,830 at 30.07
1.0%
Planned (10b5-1)
29 Apr 2026
Lu Peng Chief Medical Officer
Sold on a plan
$112.23K 3,733 at 30.06
5.6%
Planned (10b5-1)
29 Apr 2026
Lesage Anne Chief Early Development
Sold on a plan
$111.28K 3,700 at 30.08
6.2%
Planned (10b5-1)
29 Apr 2026
Lesage Anne Chief Early Development · indirect
Sold on a plan
$111.23K 3,700 at 30.06
2.4%
Planned (10b5-1)
Showing 1–50 of 60. Page 1 of 2 Older →